Every year Canadian Blood Services publishes a report highlighting its achievements in research and development. By integrating research and development into the Canadian blood system, Canadian Blood Services, through its Innovation & Portfolio Management team, delivers on the principles set out by Justice Horace Krever in the Royal Commission report that led to the founding of Canadian Blood Services more than 25 years ago.
Among the remarkable successes highlighted in this year’s report, Integrating Research & Development into the Canadian Blood System, are eight impact case studies. Each case study illustrates the tangible and various ways in which Canadian Blood Services’ investments in research and education have made a meaningful difference in Canada’s blood system and in the lives of people across the country.
“Our case studies are just one way of showing Canadian Blood Services’ steadfast commitment to safeguarding Canadians with a safe, strong and resilient blood system,” says Dr. Chantale Pambun, senior medical director in Innovation & Portfolio Management. “But the successes highlighted in this report are only made possible with a shared commitment to excellence among our teams, our collaborators and our strategic partners—heartfelt gratitude to all who have been part of our remarkable journey.”
The Innovation & Portfolio Management Annual Impact Report, 2022 – 2023, is now available on blood.ca.
Canadian Blood Services – Driving world-class innovation
Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact.
The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.